Fast MRI for close monitoring of high-risk liver cancer
Part of Cancer, Digestive system clinical trials.
This trial studies a faster MRI scan to help track early liver cancer in people who have cirrhosis and are considered high risk. It may improve how often and how well doctors can look for changes without using longer imaging sessions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 18 years old.
- You’ve been enrolled in a liver cancer screening program for at least 6 months at a specialized liver (hepatology) clinic.
- You have cirrhosis confirmed or strongly suggested by tests, and your liver ultrasound can be done (the liver area is viewable).
- Your liver function is in Child-Pugh A or B (not C).
- You have no liver cancer on a recent scan (within about 3 months), and your estimated yearly liver cancer risk is above 3%.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This trial compares a shorter MRI using a special dye to a CT scan for detecting liver cancer recurrence in people who have been cancer-free for at least two years after surgery or local treatment.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
This study looks at ways to improve screening for liver cancer in adults with long-term liver disease. It may help catch liver cancer earlier, which can make treatment easier.
This study uses a special MRI machine to take detailed images of the liver. It includes people newly diagnosed with liver cancer who haven't had treatment yet, as well as healthy volunteers for comparison. The goal is to see how well the machine works for different patients.
This study compares ultrasound scans versus MRI scans to see which one better helps prevent deaths from liver cancer in people with cirrhosis. You may be assigned to one of the two imaging tests and follow-up visits to track whether liver cancer develops or is caught early.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.